Overall, our results suggest that BRAF class 3 colorectal cancers have better survival than class 1 colorectal cancers, but the additional Ras pathway mutations in some class 3 BRAF-mutant colorectal cancers result in survival similar to that associated with class 1 V600E. Here, BRAF is linked to colorectal cancer.